ATE485052T1 - Kovalenter faktor vii-gewebefaktor-komplex - Google Patents

Kovalenter faktor vii-gewebefaktor-komplex

Info

Publication number
ATE485052T1
ATE485052T1 AT07727577T AT07727577T ATE485052T1 AT E485052 T1 ATE485052 T1 AT E485052T1 AT 07727577 T AT07727577 T AT 07727577T AT 07727577 T AT07727577 T AT 07727577T AT E485052 T1 ATE485052 T1 AT E485052T1
Authority
AT
Austria
Prior art keywords
factor
covalent
complex
factor vii
tissue
Prior art date
Application number
AT07727577T
Other languages
English (en)
Inventor
Henrik Ystergaard
Ole Olsen
Anders Klarskov Petersen
Henning Ralf Stennicke
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE485052T1 publication Critical patent/ATE485052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT07727577T 2006-04-07 2007-03-30 Kovalenter faktor vii-gewebefaktor-komplex ATE485052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112358 2006-04-07
PCT/EP2007/053105 WO2007115953A1 (en) 2006-04-07 2007-03-30 Covalent factor vii-tissue factor complex

Publications (1)

Publication Number Publication Date
ATE485052T1 true ATE485052T1 (de) 2010-11-15

Family

ID=36781437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727577T ATE485052T1 (de) 2006-04-07 2007-03-30 Kovalenter faktor vii-gewebefaktor-komplex

Country Status (8)

Country Link
US (1) US20110040073A1 (de)
EP (1) EP2007417B1 (de)
JP (1) JP5759102B2 (de)
CN (1) CN101466400B (de)
AT (1) ATE485052T1 (de)
DE (1) DE602007009956D1 (de)
ES (1) ES2353084T3 (de)
WO (1) WO2007115953A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2127640A1 (de) * 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Modifizierte azid-enthaltende Proteine
CN102804925B (zh) 2009-06-24 2014-11-26 皇家飞利浦电子股份有限公司 用于编程微控制器的方法和设备
CN102753575A (zh) * 2010-01-28 2012-10-24 诺沃—诺迪斯克保健股份有限公司 因子vii融合多肽
US20150044195A1 (en) * 2012-03-30 2015-02-12 Novo Nordisk Healthcare Ag FVIIa-sTF complexes exhibiting exosite-mediated super activity
US10202595B2 (en) 2012-06-08 2019-02-12 Bioverativ Therapeutics Inc. Chimeric clotting factors
CN104519897A (zh) 2012-06-08 2015-04-15 比奥根艾迪克Ma公司 促凝血化合物
EP2906693A1 (de) 2012-10-15 2015-08-19 Novo Nordisk Health Care AG Gerinnungsfaktor-vii-polypeptide
KR20180031775A (ko) 2015-08-12 2018-03-28 셀 머신스, 인크. 긴 반감기 응집 복합체와 관련된 방법 및 조성물
MX2021012365A (es) 2019-04-17 2021-11-17 Novo Nordisk As Anticuerpos biespecificos.
CN114836503B (zh) * 2022-04-29 2023-08-25 江苏祈瑞医药科技有限公司 一组具有肝损伤保护作用的乳清蛋白肽、高f值寡肽及其制备方法和应用
CN117860874A (zh) * 2024-03-12 2024-04-12 正大天晴药业集团南京顺欣制药有限公司 重组人凝血因子VIIa的药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788965A (en) * 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
ATE234359T1 (de) * 1995-12-01 2003-03-15 Genentech Inc Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia
ES2246069T3 (es) * 1997-05-02 2006-02-01 Genentech, Inc. Procedimiento de preparacion de anticuerpos multiespecificos que tienen componentes comunes y multimericos.
CN100488562C (zh) * 2000-02-11 2009-05-20 拜耳医药保健有限公司 凝血因子VⅡ或VⅡa样分子
EP1397484A4 (de) * 2001-03-27 2005-05-25 Massachusetts Inst Technology Verfahren und produkte im zusammenhang mit fgf-dimerisierung
ATE532858T1 (de) * 2001-09-27 2011-11-15 Novo Nordisk Healthcare Ag Menschliche gerinnungsfaktor-vii-polypeptide
JP2005508162A (ja) * 2001-10-02 2005-03-31 ジェネンテック・インコーポレーテッド Ａｐｏ−２リガンド変異体とその使用法
BR0304659A (pt) * 2002-05-01 2004-09-21 Schering Ag Fator de tecido de proteìnas de fusão alvos trombomodulina como anticoagulantes
EP1523504A2 (de) * 2002-07-12 2005-04-20 Novo Nordisk A/S Gewebe faktorbindende immunokonjugate die faktor viia enthalten
EP1673453A2 (de) * 2003-10-07 2006-06-28 Novo Nordisk Health Care AG Hybridmoleküle mit faktor vii/viia-aktivität

Also Published As

Publication number Publication date
US20110040073A1 (en) 2011-02-17
CN101466400A (zh) 2009-06-24
CN101466400B (zh) 2014-06-25
JP2009532048A (ja) 2009-09-10
ES2353084T3 (es) 2011-02-25
EP2007417B1 (de) 2010-10-20
JP5759102B2 (ja) 2015-08-05
EP2007417A1 (de) 2008-12-31
WO2007115953A1 (en) 2007-10-18
DE602007009956D1 (de) 2010-12-02

Similar Documents

Publication Publication Date Title
ATE485052T1 (de) Kovalenter faktor vii-gewebefaktor-komplex
MX2008001614A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
DE602007004086D1 (de) Acrylierte hyaluronsäure
MY145652A (en) Process for the manufacture of dihydropteridinones
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
MX2011001679A (es) Derivados de flavina.
MX336737B (es) Composiciones y metodos que comprenden variantes de proteasa serina.
MX2010007846A (es) Fabricación de enzimas sulfatasa lisosomal humana altamente fosforilada, activa y usos de las mismas.
FR2883179B1 (fr) Comprime enrobe
EA200801912A1 (ru) Лечение рака
MA33537B1 (fr) Anticorps anti-cdcp1 humanisés
MX2010010660A (es) Nuevos complejos de rutenio como catalizadores para reacciones de metatesis.
MX2010001832A (es) Composiciones para el cuidado domestico y de telas que comprenden complejos de colorante-polimero.
WO2009124330A3 (de) Behandlung von tumorerkrankungen
MY151973A (en) Cyclic depsipeptides
ATE444990T1 (de) Spritzbare akustikmassen
PT2382198E (pt) Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
NO20080993L (no) Fremgangsmate for a forbedre arvakenhet
SG129432A1 (en) Automated generation of multi-dimensional structure activity and structure property relationships
ATE496941T1 (de) Herstellung von insulinkonjugaten
DK2089433T3 (da) Behandling, der er rettet mod cathepsin S
GB0701103D0 (en) Software duplication
WO2010111257A3 (en) Targeted schiff base complexes
NZ593169A (en) Anticancer compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties